PRODUKSI IgA & IgG MUKOSAL DAN SISTEMIK SETELAH IMUNISASI PER ORAL DENGAN PROTEIN AdhO36 SALMONELLA TYPHI PADA MENCIT BALB/C

Authors

  • Sanarto Santoso Laboratorium Mikrobiologi Fakultas Kedokteran Universitas Brawijaya

DOI:

https://doi.org/10.21776/ub.jkb.2003.019.02.2

Abstract

ABSTRACT
An experiment has been conducted to determine the production of mucosal and systemic IgA and IgG after oral immunization with
AdhO36 protein Salmonella typhi using CTB as adjuvant. The results of ELISA Test, shows that AdhO36 protein Salmonella typhi
were highly significantly (p = 0.001) able to induce the production of S-IgA (secretory IgA), as compared to control and CTB treatment.
The analysis of variance results show that the effect of AdhO36 protein to the IgA content in serum is high significantly different to IgA
content in mucus (p=0.001). This finding is relevant to the previous experiments that the oral administration of AdhO36 protein can
inhibit the in vivo adhessive process of Salmonella typhi at enterocytes of Balb/c mice. Therefore, it can be concluded that AdhO36
protein  Salmonella  typhi  is  a  potential  mucosal  immunogen  which  can  induce  mucosal  immune  response  as  the  results  of  the
formation of protective S-IgA, which in turn, can inhibit the adhesive process as the initial stage of infection process at enterocytes of
Balb/c mice.  Apart from S-IgA,

Downloads

Download data is not yet available.

References

DAFTAR KEPUSTAKAAN

Pang, T., Koh, C.L., Puthucheary, S.D., Typhoid Fever: Strategies for the 90’s. Singapore: World Scientific. 1992.

Murphy, J.R., Grez, L., Immunogenicity of Salmonella typhi Ty21a vaccine for young children. Infect Immun. 1991: 59: 4291-4293.

Nataro, J.P., and Levine, M.M., Enteric Bacterial Vaccine, in: Ogra, P.L., Mestecky, J.,Lamm, M.E.,Strober, W., Bienenstock, J., McGhee, J.R., Mucosal Immunology 2nd ed, Academic Press. 1999: 851 – 865.

Salyers, A.A., and Whitt, D.D., Bacterial Pathogenesis: a molecular approach. Washington DC: American Society for Microbiology Press. 1994: 30-41, 229-241.

Todar, K.,Bacteriology 330 Lecture Topics: Colonization and Invasion. University of Wisconsin Department of Bacteriology.1997.

Salyers, A.A., and Whitt, D.D., Bacterial Pathogenesis: a molecular approach, 2nded. Washington DC; American Society for Microbiology Press. 2002: 93-94, 115-126

Henahan,S.,E.coli vaccine; Science Update. 1997.

Michalek, Suzanne, M., Childers, Noel, K., Dertzbaugh, Mark, T., Vaccination Strategies for Mucosal Pathogens, in Virulence Mechanisms of Bacterial Pathogens, 2nd ed., American Society for Microbiology, Washington,D.C. 1995: 269-301.

Santoso, S., Protektivitas in vivo protein AdhO36 Salmonella typhi isolat Malang pada mencit Balb/c,Majalah Kedokteran Universitas Brawijaya Malang. 2002: 8(3): 51-59

McGhee, J.R., Lamm, M.E., Strober, W., Mucosal Immune Responses : An Overview in Ogra, P.L., Mestecky, J., Lamm, M.E., Strober, W., Bienenstock, J., McGhee, J.R., Mucosal Immunology 2nd ed, Academic Press. 1999: 485 – 506.

Finegold, S.M., Barron, E.J., Bailey and Scott’s Diagnostic Microbiology, 7th ed. CV Mosby Company, USA. 1986: 682, 862, 863, 879.

Ehara, M., Ishibashi, M., Ichinose, Y., Iwanaga, M., Shimotori, S., Naito, T., Purification and partial characterization of fimbriae of Vibrio cholerae O-1, Vaccine. 1986: 5: 283-286.

Sumarno, Karakterisasi Molekuler Protein Adesi Vibrio cholerae O1 M094V dan Protein Reseptornya pada Sel Epitel Usus Halus Tikus Putih (Wistar), Studi Patogenesis Vibrio cholerae O1 M094V. Disertasi Program Pasca Sarjana Universitas Airlangga Surabaya.2000.

Dhaenens, L., Szczebara, F., Husson, M.O., Identification, Characterization and Immunogenicity of Lactoferrin-Binding Protein from Helicobacter pylori, Infect Immun.1997:65(5):514-518.

Laemli, U.K., Cleavage of Structural Protein during the Assembly of the Head of Bacteriophage T4, Nature. 1970: 227: 680-686.

Hernandez, A.M., Gavilanes-Parra, S., Chavez-Berrocal, M., Molina-Lopez, J., Cravioto, A., Binding of Diarrheagenic Escherichia coli to 32 to 33 Kilodalton Human Intestinal Brush Border Proteins. Infect Immun. 1997: 65:4494-4501.

Strober, W., and Fuss, I.J., The Mucosal Immune System in: Stites DP, Terr AI, Parslow TG Medical Immunology, 9th ed. Appleton & Lange. 1997: 196-209.

Elson, C.O., and Dertzbaugh, M.T., Mucosal Adjuvants in: Ogra, P.L., Mestecky, J., Lamm, M.E., Strober, W., Bienenstock, J., McGhee, J.R., Mucosal Immunology 2nd ed, Academic Press. 1999: 817 – 838.

Elson, C.O., Cholera toxin as a Mucosal Adjuvant, in Ogra, P.L., Lamm, M.E., Bienenstock, J., Mestecky, J.,Strober, W., McGhee, J.R., Mucosal Vaccine, Academic Press. 1996: 59 – 72.

Mestecky, J., McGhee, J.R., Immunoglobulin A (IgA): Molecular and Cellular Interactions Involved in IgA Biosynthesis and Immune response. Adv.Immunol. 1987: 40: 153 – 245.

Mestecky, J., Moro, I., Underdown, B.J., Mucosal Immunoglobulins in: Ogra, P.L., Mestecky, J., Lamm, M.E., Strober, W., Bienenstock, J., McGhee, J.R., Mucosal Immunology, 2nd ed., Academic Press. USA. 1999: 133 – 152.

Jackson, R.J.,Fujihashi, K., Xu-Amanao,J.,Kiyono, H., and McGhee,J.R., Optimizing Oral Vaccines: Induction of Systemic and Mucosal B cell and Antibody Responses to Tetanus Toxoid by use of Cholera Toxin as Adjuvant, Infect Immun. 1993: 61: 4272–4279.

Snider, D.P., Marshall, J.S., Perdue, M.H., and Liang, H., Production of IgE Antibody and Allergic Sensitization of Intestinal and Pheripheral Tissues after Oral Immunization with Protein Ag and Cholera toxin, J.Immunol. 1994: 153: 647 – 657.

Abbas, Abul, K., Lichtman, Andrew, H., Pober, Jordan, S., Cellular and Molecular Immunology, 4th ed. W.B. Saunders Company. 2000: 199, 331 - 333.

Janeway, C.A., Travers, P., Walport, M., Capra, J.D., Immunobiology, The Immune System in Health and Disease 4th ed., Elsevier Science Ltd/Garland Publishing. 1999: 314 - 316.

Bouvet, J.P., and Fischetti, V.A., Diversity of Antibody-Mediated Immunity at the Mucosal Barrier. Infect Immun. 1999: 67: 2687-2691.

Levine, M.M., and Sztein, M.B., Human Mucosal Vaccines for Salmonella typhi Infections, in: Kiyono H, Ogra PL, McGhee JR, Mucosal Vaccines. Academic Press, Inc. USA. 1996: 201 – 211.

Downloads

Published

2013-03-23

Issue

Vol. 19 No. 2 (2003)

Section

Original Article

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).